Endobronchial Intubation of Double-lumen Tube: Conventional Method vs Fiberoptic Bronchoscope Guide Method
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03368599 |
|
Recruitment Status :
Completed
First Posted : December 11, 2017
Last Update Posted : September 10, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Double lumen tube (DLT) needs to be intubated to isolate ventilations of left and right lungs for thoracic surgery. Post-operative sore throat and hoarseness are more frequent with DLT intubation than with single one. Which is may because DLT is relatively thicker, harder, sideway curved and therefore more likely to damage the vocal cord or trachea during intubation, and advanced deeper to the carina and main bronchus level. In the conventional method of intubation, DLT is rotated 90 degrees and advanced blindly to the main bronchus level after DLT is intubated through vocal cord using the direct laryngoscopy. After the blind advancement, the sufficient tube position needs to be gained and confirmed with the fiberoptic bronchoscope. In the bronchoscope guide method, after DLT is intubated through vocal cord using the direct laryngoscopy, the pathway into the targeted main bronchus is secured using the fiberoptic bronchoscope which is passed through a bronchial lumen of DLT. And then DLT can be advanced through the guide of the bronchoscope. In this study, we intend to compare post-operative sore throat, hoarseness and airway injury between the two methods. We hypothesize that the bronchoscope guide method can reduce the post-operative complications and airway injury because surrounding tissues of the airway can be less irritated by DLT intubation in the guide method than in a conventional.
For a constant guide effect, we use fiberoptic bronchoscopes with same outer diameter (4.1 mm) which can pass through a bronchial lumen of 37 and 39 Fr Lt. DLT and cannot pass through 35 Fr or smaller Lt. DLTs.
<Lt. DLT size selection>
- male: ≥160 cm, 39 French; < 160 cm, 37 French
- female: ≥160 cm, 37 French; < 160 cm, contraindication
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Intubation, Intratracheal Postoperative Complications Sore Throat Hoarseness Soft Tissue Injuries Thoracic Surgery | Procedure: Bronchoscope guided advancement Procedure: Conventional advancement | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 136 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Outcomes Assessor) |
| Primary Purpose: | Prevention |
| Official Title: | The Effect of Endobronchial Intubation of Double-lumen Tube on Post-operative Sore Throat, Hoarseness and Airway Injuries: A Comparison Between Conventional and Fiberoptic Bronchoscope-guided Intubation |
| Actual Study Start Date : | January 15, 2018 |
| Actual Primary Completion Date : | January 30, 2019 |
| Actual Study Completion Date : | January 31, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Bronchoscope guide group
DLT is advanced into the main bronchus through the guide of fiberoptic bronchoscope (Bronchoscope guided advancement).
|
Procedure: Bronchoscope guided advancement
During the anesthetic induction for thoracic surgery, Lt. DLT is intubated using the bronchoscope-guided method. The method is as follows.
|
|
Active Comparator: Conventional group
DLT is advanced blindly to the main bronchus level (Conventional advancement).
|
Procedure: Conventional advancement
During the anesthetic induction for thoracic surgery, Lt. DLT is intubated using the conventional method. The method is as follows.
|
- Post-operative sore throat (24 h) [ Time Frame: 24 hour after tracheal extubation ]The degree of throat pain (Visual Analogue Scale (VAS); 0, no pain; 10, most
- Resistance against DLT passage through vocal cord [ Time Frame: Intraoperative ]none/mild/severe
- Resistance against DLT advancement [ Time Frame: Intraoperative ]none/mild/severe
- Intubation time [ Time Frame: Intraoperative ]stop of initial mask ventilation - intubation through vocal cord
- The number of attempts for intubation [ Time Frame: Intraoperative ]The number of attempts for intubation through vocal cord
- The number of right misplacement of Lt. DLT [ Time Frame: Intraoperative ]The number of right misplacement of Lt. DLT confirmed using the fiberoptic bronchoscope after the advancement
- Time for DLT positioning: stop of initial mask ventilation - success of the 1st fine DLT positioning [ Time Frame: Intraoperative ]Time for DLT positioning: stop of initial mask ventilation - success of the 1st fine DLT positioning into Lt. main bronchus
- Heart rate [ Time Frame: Intraoperative ]Heart rate Just before Lt. DLT intubation / 2 min after success of the 1st fine DLT positioning
- Mean arterial pressure [ Time Frame: Intraoperative ]Mean arterial pressure Just before Lt. DLT intubation / 2 min after success of the 1st fine DLT positioning
- IV PCA [ Time Frame: At 24 hours after the extubation ]Fentanyl usage with PCA
- Airway injury (Lt. main bronhcus, carina, trachea) [ Time Frame: Intraoperative ]When spontaneous breathing of the patient starts after the thoracic surgery
- Airway injury (vocal cord) [ Time Frame: Intraoperative ]When spontaneous breathing of the patient starts after the thoracic surgery
- Post-operative sore throat (1 h) [ Time Frame: 24 hours after tracheal extubation ]The degree of throat pain (Visual Analogue Scale (VAS); 0, no pain; 10, most pain) after tracheal extubation
- Post-operative hoarseness (1 h) [ Time Frame: 1 hour after tracheal extubation ]The incidence of hoarseness after tracheal extubation
- Post-operative hoarseness (24 h) [ Time Frame: 24 hour after tracheal extubation ]The incidence of hoarseness after tracheal extubation
- Oral dryness [ Time Frame: 24 hours after tracheal extubation ]The incidence of oral dryness
- Dysphagia [ Time Frame: 24 hours after tracheal extubation ]The incidence of dysphagia
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 75 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- ASA (American Society of Anesthesiologists) class I - III
- Elective thoracic surgery
- Left-sided DLT intubation for one-lung ventilation
Exclusion Criteria:
- Female, height < 160 cm
- Pre-existing sore throat, hoarseness or airway injury
- Duration of surgery > 6 h
- Upper respiratory tract infection
- Cervical spine diseases
- Presence of tracheostomy
- Pharyngeal neoplasm or abscess which can induce mechanical airway obstruction
- Mallampati score 4
- Obesity (BMI ≥ 35 kg/m2)
- Obstructive sleep apnea (OSA)
- Craniofacial anomaly
- Cormack grade 3b or 4
- History or high risk of difficult intubation / difficult mask ventilation
- Patients whom the direct laryngoscopy cannot be used for, because of weak teeth or small mouth opening
- Patients who refuse to participate in the study or from whom receive informed consent cannot be received.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03368599
| Korea, Republic of | |
| Seoul National University Bundang Hospital | |
| Seongnam-si, Gyeonggi-do, Korea, Republic of, 13620 | |
| Principal Investigator: | Jin-Woo Park, MD | Seoul National University Bundang Hospital |
Other Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Jin-Woo Park, Assistant Professor, Seoul National University Bundang Hospital |
| ClinicalTrials.gov Identifier: | NCT03368599 |
| Other Study ID Numbers: |
B-1711-432-005 |
| First Posted: | December 11, 2017 Key Record Dates |
| Last Update Posted: | September 10, 2019 |
| Last Verified: | September 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Pharyngitis Hoarseness Dysphonia Postoperative Complications Soft Tissue Injuries Pathologic Processes Respiratory Tract Infections Infections Pharyngeal Diseases Stomatognathic Diseases |
Respiratory Tract Diseases Otorhinolaryngologic Diseases Wounds and Injuries Voice Disorders Laryngeal Diseases Respiration Disorders Neurologic Manifestations Nervous System Diseases Signs and Symptoms, Respiratory |

